A federal jury convicted a medical doctor yesterday for his participation in conspiracies to commit health care fraud and wire fraud and to unlawfully distribute controlled substances.
According to court documents and evidence presented at trial, Neil K. Anand M.D., 48, of Bensalem, Pennsylvania, conspired to submit false and fraudulent claims to Medicare, health plans provided by the U.S. Office of Personnel Management (OPM), Independence Blue Cross (IBC), and Anthem, for “Goody Bags” of medically unnecessary prescription medications, which were dispensed to patients by in-house pharmacies owned by Anand. As the evidence at trial showed, the conspirators required patients to take the Goody Bags, which they did not need or want, to receive prescriptions for controlled substances. In total, Medicare, OPM, IBC, and Anthem paid over $2.3 million for the Goody Bags. Anand also conspired to distribute oxycodone outside the usual course of professional practice and without a legitimate medical purpose. In furtherance of the conspiracy, unlicensed medical interns wrote prescriptions for controlled substances using blank prescriptions that were pre-signed by Anand. Anand prescribed 20,850 oxycodone tablets for nine different patients, as part of the scheme. After learning that he was under investigation, Anand concealed the proceeds of the fraud by transferring approximately $1.2 million into an account in the name of his father and for the benefit of his minor daughter.
Anand was convicted of conspiracy to commit health care fraud and wire fraud; three counts of health care fraud; one count of money laundering; four counts of unlawful monetary transactions; and conspiracy to distribute controlled substances. He is scheduled to be sentenced on Aug. 19 and faces a statutory maximum penalty of 130 years in prison. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.
Matthew R. Galeotti, Head of the Justice Department’s Criminal Division; Special Agent in Charge Maureen Dixon of the Department of Health and Human Services Office of the Inspector General (HHS-OIG); Special Agent in Charge Kathleen Woodson of the U.S. Postal Service Office of Inspector General (U.S. Postal Service OIG); and Special Agent in Charge of Investigative Operations Derek Holt of the OPM-Office of the Inspector General (OPM-OIG) made the announcement.
The HHS-OIG, U.S. Postal Service OIG, and OPM OIG investigated the case. FBI’s Philadelphia Field Office provided valuable assistance.
Trial Attorneys Paul J. Koob, Patrick J. Campbell, and Arun Bodapati of the Criminal Division’s Fraud Section are prosecuting the case.